WHTS

WHTS is a biotechnology company focused on the discovery and development of novel therapeutic agents for the treatment of oncology and infectious diseases. The company leverages its expertise in medicinal chemistry and molecular biology to identify and optimize small molecule candidates with the potential to address significant unmet medical needs. WHTS's current pipeline is primarily in the pre-clinical stage, with several programs undergoing lead optimization and early-stage evaluation. The company aims to advance its most promising candidates into clinical development through strategic partnerships and internal research efforts.